BUZZ-派珀桑德勒公司给予雅培 "增持 "评级

Reuters
19 Sep 2024

((自动化翻译由路透提供,请见免责声明 ))

9月19日 - ** 券商Piper Sandler启动对雅培实验室 的评级,给予增持评级,目标价131美元。

* (link) * 尽管执行力很强,但由于早产儿坏死性小肠结肠炎$(NEC.AU)$ 的诉讼仍在进行,ABT股价在今年表现不佳,这已经成为一个悬念。

** 券商认为,与诉讼相关的潜在损害赔偿已经定价

** 认为 ABT 是 "质量较高的大市值医疗科技公司之一"。

** 预计公司 2025 年的每股收益将恢复两位数增长

** ABT 股价今年累计上涨 3.3

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10